1. Home
  2. MYND vs NRXP Comparison

MYND vs NRXP Comparison

Compare MYND & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • NRXP
  • Stock Information
  • Founded
  • MYND 1998
  • NRXP 2015
  • Country
  • MYND Cayman Islands
  • NRXP United States
  • Employees
  • MYND N/A
  • NRXP N/A
  • Industry
  • MYND Other Consumer Services
  • NRXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • MYND Real Estate
  • NRXP Health Care
  • Exchange
  • MYND Nasdaq
  • NRXP Nasdaq
  • Market Cap
  • MYND 38.8M
  • NRXP 34.7M
  • IPO Year
  • MYND 2017
  • NRXP N/A
  • Fundamental
  • Price
  • MYND $0.85
  • NRXP $1.87
  • Analyst Decision
  • MYND
  • NRXP Strong Buy
  • Analyst Count
  • MYND 0
  • NRXP 4
  • Target Price
  • MYND N/A
  • NRXP $28.25
  • AVG Volume (30 Days)
  • MYND 16.8K
  • NRXP 186.3K
  • Earning Date
  • MYND 04-15-2025
  • NRXP 05-13-2025
  • Dividend Yield
  • MYND N/A
  • NRXP N/A
  • EPS Growth
  • MYND N/A
  • NRXP N/A
  • EPS
  • MYND N/A
  • NRXP N/A
  • Revenue
  • MYND $267,380,999.00
  • NRXP N/A
  • Revenue This Year
  • MYND N/A
  • NRXP N/A
  • Revenue Next Year
  • MYND N/A
  • NRXP N/A
  • P/E Ratio
  • MYND N/A
  • NRXP N/A
  • Revenue Growth
  • MYND N/A
  • NRXP N/A
  • 52 Week Low
  • MYND $0.61
  • NRXP $1.10
  • 52 Week High
  • MYND $4.69
  • NRXP $6.01
  • Technical
  • Relative Strength Index (RSI)
  • MYND 33.74
  • NRXP 37.68
  • Support Level
  • MYND $0.84
  • NRXP $1.95
  • Resistance Level
  • MYND $0.90
  • NRXP $2.12
  • Average True Range (ATR)
  • MYND 0.08
  • NRXP 0.17
  • MACD
  • MYND 0.01
  • NRXP 0.01
  • Stochastic Oscillator
  • MYND 6.59
  • NRXP 10.00

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: